【摘要】 目的:观察双黄连口服液联合利巴韦林颗粒治疗小儿上呼吸道感染的临床疗效。方法:选取100例上呼吸道感染患儿为研究对象,随机分为试验组和对照组各50例。试验组予双黄连口服液联合利巴韦林颗粒治疗,对照组单纯采用利巴韦林颗粒治疗。治疗后比较2组临床疗效,观察患儿临床症状的改善情况及不良反应发生情况。结果:试验组总有效率96.0%,对照组总有效率80.0%,2组比较,差异有统计学意义(P<0.05)。试验组发热、咽红、恶寒、鼻塞流涕、咳嗽、泛恶及喷嚏的改善情况均优于对照组,差异均有统计学意义(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:双黄连口服液联合利巴韦林颗粒治疗小儿上呼吸道感染安全有效,能显著改善患儿的症状。更多还原

【Abstract】 Objective:To observe the clinical effect of Shuanghuanglian oral liquid combined with ribavirin granules for children with upper respiratory tract infection. Methods:Selected 100 cases of children with upper respiratory tract infection as study objects and divided them into the experiment group and the control group randomly,50 cases in each group. The experiment group received Shuanghuanglian oral liquid combined with ribavirin granules for treatment,while thecontrol group only received ribavirin granules. Compared the clinical effect in the two groups and observed the improvements of clinical symptoms and the occurrence of adverse reactions of children after treatment. Results:The total effective rate was 96.0% in the experiment group and was 80.0% in the control group,difference being significant(P < 0.05). The improvement of fever,red pharyngeal, aversion to cold, nasal obstruction and nasal discharge, cough, nausea and sneezing in the experiment group was better than that in the control group,differences being significant(P < 0.05). No significant difference was found in the comparison of the incidence of adverse reactions between the two groups(P > 0.05). Conclusion: The therapy of Shuanghuanglian oral liquid combined with ribavirin granules for children with upper respiratory tract infection is safe and effective,which can obviously improve symptoms of children.更多还原